Cargando…
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
Autores principales: | Sécher, Thomas, Mayor, Alexie, Heuzé-Vourc'h, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896187/ https://www.ncbi.nlm.nih.gov/pubmed/31849954 http://dx.doi.org/10.3389/fimmu.2019.02760 |
Ejemplares similares
-
Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives
por: Mayor, Alexie, et al.
Publicado: (2021) -
Inhaled antibodies: formulations require specific development to overcome instability due to nebulization
por: Mayor, Alexie, et al.
Publicado: (2021) -
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
por: Pitiot, Aubin, et al.
Publicado: (2022) -
Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States
por: Ferreira, Marion, et al.
Publicado: (2021) -
Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
por: Guillon, Antoine, et al.
Publicado: (2017)